................................ 50 OSE Immunotherapeutics v2.2 Study OSE2101C301 (ATALANTE 1) Statistical Analysis Plan 2021 -07-23 IND#: BB-IND 10802 CONFIDENTIAL P a g e | 5/51 LIST OF TABLES Table 1 Schedule of Time and Events for Arm A ................................ ................................